Federal Supply Schedule 36F79720D0132
Award Date
6/1/20
Last Date to Order
10/15/23
Federal Agency
Veterans Integrated Service Network 12
Awardee
Nabriva Therapeutics US Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for VHA facilities. The prime contractor is Vyne Pharmaceuticals Inc., doing business as Menlo Therapeutics, with a potential value of $225,000 over the period of performance from August 2020 through August 2022. The contract was...
The federal supply schedule contract provides pharmaceuticals and drugs under GSA schedule 65 IB. Awarded by the Department of Veterans Affairs Veterans Health Administration VISN 12, the multiple award contract has a potential value of $225,000. Nnodum Pharmaceuticals Corporation, an 8A certified small disadvantaged minority-owned business, is the prime contractor. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA to support veterans' healthcare...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs to Thea Pharma, Inc., a for-profit foreign-owned organization, to provide drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $500,000.00 and a period of performance from February 1, 2023 to January 31, 2028. As a Federal Supply Schedule contract, it is a multiple-award vehicle with no set-asides. The purpose of this contract is to enable federal agencies, primarily...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12, provides Drugs, Pharmaceuticals, and Hematology Related Products. The prime contractor is Tris Pharma Inc., a self-certified small disadvantaged business manufacturer of goods, with a contract ceiling value of $28,000,000 over the period of performance from September 1, 2023 to August 31, 2028. The contract is a multiple award vehicle, with no set-asides used. While the...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to STI Pharma LLC, a for-profit limited liability company and manufacturer of goods, on August 15, 2017, with a ceiling value of $225,000.00 and a period of performance through May 14, 2026. The contract is part of the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, a multiple-award...